I-SPY 2: optimising cancer drug development in the 21st century

Por Bartsch, Rupert, de Azambuja, Evandro
Publicado no ESMO Open (2016)

Threat posed by unproven drugs in medical oncology

Por Pondé, Noam, Ades, Felipe, de Azambuja, Evandro
Publicado no ESMO Open (2016)

Phosphoethanolamine and the danger of unproven drugs

Por Pondé, Noam, de Azambuja, Evandro, Ades, Felipe
Publicado no Ecancermedicalscience (2016)

Twenty years of anti-HER2 therapy-associated cardiotoxicity

Por Pondé, Noam F, Lambertini, Matteo, de Azambuja, Evandro
Publicado no ESMO Open (2016)

How Long is Enough – Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast Cancer

Por Pinto, Ana Catarina, de Azambuja, Evandro, Piccart-Gebhart, Martine
Publicado em 2013

Are we HER-ting for innovation in neoadjuvant breast cancer trial design?

Por Snoj, Natasa, Bedard, Philippe L, de Azambuja, Evandro, Cardoso, Fatima, Piccart, Martine
Publicado em 2009

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA

Por Ades, Felipe, Senterre, Christelle, Zardavas, Dimitrios, de Azambuja, Evandro, Popescu, Razvan, Piccart, Martine
Publicado no PLoS One (2017)

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence

Por Rossari, José R., Metzger-Filho, Otto, Paesmans, Marianne, Saini, Kamal S., Gennari, Alessandra, de Azambuja, Evandro, Piccart-Gebhart, Martine
Publicado em 2012

Information perception, wishes, and satisfaction in ambulatory cancer patients under active treatment: patient-reported outcomes with QLQ-INFO25

Por Pinto, Ana Catarina, Ferreira-Santos, Fernando, Lago, Lissandra Dal, de Azambuja, Evandro, Pimentel, Francisco Luís, Piccart-Gebhart, Martine, Razavi, Darius
Publicado em 2014

Targeted therapies in breast cancer: are heart and vessels also being targeted?

Por Criscitiello, Carmen, Metzger-Filho, Otto, Saini, Kamal S, de Castro Jr, Gilberto, Diaz, Marie, La Gerche, André, de Azambuja, Evandro, Piccart-Gebhart, Martine J
Publicado em 2012

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

Por Metzger-Filho, Otto, de Azambuja, Evandro, Procter, Marion, Krieguer, Magalie, Smith, Ian, Baselga, Jose, Cameron, David, Untch, Michael, Jackisch, Christian, Bell, Richard, Gianni, Luca, Goldhirsch, Aron, Piccart, Martine, Gelber, Richard D.
Publicado no Breast Cancer Res Treat (2015)

Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial

Por Dowsett, Mitch, Procter, Marion, McCaskill-Stevens, Worta, de Azambuja, Evandro, Dafni, Urania, Rueschoff, Josef, Jordan, Bruce, Dolci, Stella, Abramovitz, Mark, Stoss, Oliver, Viale, Giuseppe, Gelber, Richard D., Piccart-Gebhart, Martine, Leyland-Jones, Brian
Publicado em 2009

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients

Por Lambertini, Matteo, Pinto, Ana Catarina, Ameye, Lieveke, Jongen, Lynn, Del Mastro, Lucia, Puglisi, Fabio, Poggio, Francesca, Bonotto, Marta, Floris, Giuseppe, Van Asten, Kathleen, Wildiers, Hans, Neven, Patrick, de Azambuja, Evandro, Paesmans, Marianne, Azim Jr, Hatem A
Publicado no Br J Cancer (2016)

Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study

Por Azim, Hatem A., Kroman, Niels, Paesmans, Marianne, Gelber, Shari, Rotmensz, Nicole, Ameye, Lieveke, De Mattos-Arruda, Leticia, Pistilli, Barbara, Pinto, Alvaro, Jensen, Maj-Britt, Cordoba, Octavi, de Azambuja, Evandro, Goldhirsch, Aron, Piccart, Martine J., Peccatori, Fedro A.
Publicado em 2013

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer

Por Palmieri, Carlo, Macpherson, Iain RJ, Yan, Kelvin, Ades, Felipe, Riddle, Pippa, Ahmed, Riz, Owadally, Waheeda, Stanley, Barbara, Shah, Deep, Gojis, Ondrej, Januszewski, Adam, Lewanski, Conrad, Asher, Rebecca, Lythgoe, Daniel, de Azambuja, Evandro, Beresford, Mark, Howell, Sacha J.
Publicado no Oncotarget (2015)

Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastu...

Por O'Sullivan, Ciara C., Bradbury, Ian, Campbell, Christine, Spielmann, Marc, Perez, Edith A., Joensuu, Heikki, Costantino, Joseph P., Delaloge, Suzette, Rastogi, Priya, Zardavas, Dimitrios, Ballman, Karla V., Holmes, Eileen, de Azambuja, Evandro, Piccart-Gebhart, Martine, Zujewski, Jo Anne, Gelber, Richard D.
Publicado no J Clin Oncol (2015)

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

Por Sonnenblick, Amir, de Azambuja, Evandro, Agbor-tarh, Dominique, Bradbury, Ian, Campbell, Christine, Huang, Yingjie, Dueck, Amylou C., Pritchard, Kathleen I., Wolff, Antonio C., Jackisch, Christian, Lang, Istvan, Untch, Michael, Smith, Ian, Boyle, Frances, Xu, Binghe, Gomez, Henry, Perez, Edith A., Piccart, Martine, Azim, Hatem A.
Publicado no J Natl Cancer Inst (2016)

Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience

Por Metzger-Filho, Otto, de Azambuja, Evandro, Bradbury, Ian, Saini, Kamal S., Bines, José, Simon, Sergio D., Dooren, Veerle Van, Aktan, Gursel, Pritchard, Kathleen I., Wolff, Antonio C., Smith, Ian, Jackisch, Christian, Lang, Istvan, Untch, Michael, Boyle, Frances, Xu, Binghe, Baselga, Jose, Perez, Edith A., Piccart-Gebhart, Martine
Publicado em 2013

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer

Por Ignatiadis, Michail, Zardavas, Dimitrios, Lemort, Marc, Wilke, Celine, Vanderbeeken, Marie-Catherine, D’Hondt, Veronique, De Azambuja, Evandro, Gombos, Andrea, Lebrun, Fabienne, Dal Lago, Lissandra, Bustin, Fanny, Maetens, Marion, Ameye, Lieveke, Veys, Isabelle, Michiels, Stefan, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Nogaret, Jean-Marie, Piccart, Martine, Awada, Ahmad
Publicado no PLoS One (2016)

PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer

Por Majewski, Ian J., Nuciforo, Paolo, Mittempergher, Lorenza, Bosma, Astrid J., Eidtmann, Holger, Holmes, Eileen, Sotiriou, Christos, Fumagalli, Debora, Jimenez, Jose, Aura, Claudia, Prudkin, Ludmila, Díaz-Delgado, Maria Carmen, de la Peña, Lorena, Loi, Sherene, Ellis, Catherine, Schultz, Nikolaus, de Azambuja, Evandro, Harbeck, Nadia, Piccart-Gebhart, Martine, Bernards, René, Baselga, José
Publicado no J Clin Oncol (2015)